LAB
NEWS
October
1995 . . . . . . . . . . Vol. 38 No. 1
Chairman:
Peter Jatlow,
M.D.
Editors: Edward L. Snyder, M.D.; Petrie M. Rainey, M.D.,
Ph.D.
Production Assistant: Terri M. Fiondella
Contributors: Frank Bia, M.D.; Stephen Edberg, Ph.D.; Steve
Mechanic, M.D.; Brian Smith, M.D.; Petrie Rainey, M.D., Ph.D.; Mark
Velleca, M.D., Ph.D.
DEFERRAL
OF PATIENTS FOR AUTOLOGOUS BLOOD DONATION
One
sequelae of the AIDS crisis has been the enormous growth of autologous
transfusion. Autologous transfusion is receiving a transfusion of
your own previously donated blood compared with the more common homologous
transfusion which is transfusion between volunteer blood donors and
recipients. All blood donated for homologous transfusion is extensively
tested for the possibility of transfusion transmissible disease (TTD),
specifically HIV1/2, HTLV-I, HBsAg, HBcAb, HCV, RPR. In addition,
the FDA has recently announced its intent to require testing for HIV
antigen (p24) with the intent to reduce the incidence of HIV positive
units which is presently running at about 1:500,000. Even with all
the testing the risk of contracting a disease from a unit of blood
is still not zero, a fact that weighs on the minds of people facing
hospitalization and surgery.
Recently, an article in the New England Journal of Medicine (1)
reported that the cost of autologous donation was exceedingly high
when measured against the actual risk of contracting a transfusion
transmitted disease. The article measured the benefits of autologous
donation only in terms of cost and did not consider the enormous
psychological comfort that autologous donation provides. Generally
patients are highly motivated to donate their own blood. The Medical
staff at Yale New Haven Hospital is aware of and supportive of the
autologous program. The Blood Bank Transfusion Unit on CB 363 presently
collects approximately 1600 autologous units per year. Unfortunately,
not every patient can donate and not every visit to donate results
in a donation. Ensuring the safety of the patient both as a donor
and as a future recipient is of utmost importance, to the staff
in the transfusion clinic and Blood Bank. A variety of circumstances
can compromise that safety, resulting in deferral from donation.
Donor
Deferral
Deferral will usually fall into two broad categories, donor safety
and transfusion or recipient safety. Patients are deferred because
they might not tolerate the donation itself, in effect the acute
blood loss may put the patient at risk because of the loss of either
volume or red cell mass. Common examples are patients with cardiomyopathy
or anemic patients. The second major cause for deferral is that
the donation may result in an unsafe unit of blood. The most common
example of this is the patient who may be intermittently bacteremic
from a chronic infection such as osteomyelitis. Transfusing bacteremic
blood could have catastrophic consequences.
Donor
Standards
We follow the donor standard guidelines that have been established
by the American Association of Blood Banks. These standards include
a minimum body weight for the donor, vital sign limits for temperature,
pulse and blood pressure, and minimum hemoglobin or hematocrit values.
In addition, the "Standards" do not permit collection
from anyone who is being treated for bacteremia or has a bacterial
infection which may be associated with bacteremia. Finally, the
donation should occur no closer than 72 hours prior to surgery.
The donor's body weight is important because it correlates to the
donor's total blood volume. The approved and licensed blood collecting
bags are manufactured to contain and store a standard range of blood
volumes. More or less blood would result in an alteration of the
ratio of added anticoagulants and nutrient solutions which could
have an adverse effect on the stored blood. Collecting a standard
unit which is 450mL (+/- 10%) and approximately 9.2% of a normal
weight (70Kg) person, from a smaller individual could result in
excessive blood loss which could produce signs and symptoms of anemia
or more likely hypovolemia. The most serious risks would be acute
hypotension and low oxygen-carrying capacity resulting in possible
organ ischemia. Therefore, the lowest acceptable weight is 110 lbs.
The pulse must be between 50 and 100 beats per minute and the blood
pressure must measure no more than 100 diastolic and 180 systolic.
These are a relatively direct evaluation of cardiovascular stability,
which is obviously necessary for a donor to sustain an acute blood
loss. In addition, abnormalities in pulse and blood pressure may
be associated with and reflect underlying diseases which may have
an impact on the ability to donate. It is the responsibility of
the Blood Bank physician to evaluate the patient's ability to donate
under these circumstances. The Blood Bank director or his physician
staff have both the responsibility and the legal authority to make
the final decision regarding the acceptability of a donor who wishes
to donate autologous blood. This responsibility cannot be transferred
to the patient's referring physician.
The temperature must be < 99.5 F. This is an important measure
of the possibility of ongoing (intercurrent) infection. While we
all recognize that autologous donation is aimed at avoiding viral
infection, it is often overlooked that the blood must also be free
of any bacteria. One frequently encountered problem is "one
stop shopping" for presurgical work-up. Patients are sent for
a variety of preadmission tests that often include invasive procedures
such as biopsies and then are sent to donate blood. Since there
is a fresh open wound, we cannot reasonably rule out the possibility
of a transient bacteremia. Bacterially contaminated units even when
stored in a refrigerator may become grossly infected. This is especially
true of the cryophilic or cold loving bacteria such as Yersinia
enterocolitica. While very common ailments, such as urinary
tract infections and upper respiratory tract infections are the
most frequent reasons for bacteremic deferral other situations such
as the presence of indwelling catheters, orthopedic appliances,
abscesses and being on antibiotic therapy for almost any reason
also fall into this category. The medical staff of the Blood Bank
assesses the entire clinical picture before turning anyone away.
Fortunately there is usually enough time to allow the condition
to resolve so that donation can be safely performed at a another
visit.
The patient must have a hematocrit sufficient to sustain an acute
blood loss without causing an iatrogenic anemia that might eventually
require transfusion support. Obviously there is little sense in
taking blood out only to have to put it back in. The minimum acceptable
hematocrit is 33%. In an adult, each unit of blood donated will
probably result in a 3 point drop in hematocrit. In essence, autologous
donation is discouraged if the predicted hematocrit is going to
be much below 30% at the time of surgery.
While every effort is made to accommodate both the patient's wish
and the referring physician's request that the patient donate autologous
blood, some individuals cannot for the reasons discussed above.
One practical solution is using blood expressly donated for the
patient by people selected by the patient. Frequently this will
be members of the patient's family but is not limited to them alone.
This is called directed donation. There are some drawbacks however.
Directed donor blood undergoes the same testing that volunteer blood
does and is not known to be any safer than volunteer donor blood.
The incidence of hepatitis is actually somewhat greater in directed
donor blood and the incidence of HIV is about the same as compared
to volunteer donor blood. The reason for this finding is that directed
donors are more likely to be first time donors. The volunteer donor
pool consists of a great many repeat donors who have already been
multiply tested for TTD markers. Anyone who tests positive for a
TTD marker such as hepatitis is permanently deferred. Beyond this,
the donor's blood type must be serologically compatible for ABO
and Rh for the unit to be useable. Another consideration is that
directed donations are not collected at Yale due to FDA licensing
restrictions. Directed donation can be arranged with the Connecticut
Red Cross in Farmington. Directed donor blood is generally not covered
under most insurance plans.
You can arrange an autologous donation at Yale New Haven Hospital
by making an appointment with the Transfusion Service at 785-4707.
Please call Dr. Steven Mechanic, the Assistant Director or Dr. Edward
Snyder, the Director of the Blood Bank at 785-2441 if you have any
medical questions. You may also call Judy Cohen, R.N. at 785-4707
for scheduling questions.
References
- Etchason,
M. et al. Cost Effectiveness of preoperative blood donation. NEJM,
1995; 332:719.
Steven Mechanic, M.D
|